Summary: Filmmaker Vikram Gandhi interviews MAPS-sponsored researcher Ingmar Gorman, Ph.D. (c), to discuss clinical studies of MDMA-assisted psychotherapy for chronic, treatment-resistant posttraumatic stress disorder (PTSD). Gorman speaks about how The New School encouraged his pursuit of psychedelic research. “This is a novel treatment that shows potential. There are some people who went through the MDMA studies who no longer meet criteria for PTSD,” explains Gorman.
Originally appearing here.
What treatments make for breakthrough psychotherapy? Ingmar Gorman, a PhD candidate in Clinical Psychology at The New School for Social Research is on the bleeding-edge of new therapeutic approaches towards the treatment of PTSD.